Yourgene Health (YGEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.28p
   
  • Change Today:
    -0.010p
  • 52 Week High: 10.00
  • 52 Week Low: 0.28
  • Currency: UK Pounds
  • Shares Issued: 3,176.96m
  • Volume: 7,150,502
  • Market Cap: £8.90m

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest ShareCast News

Yourgene CFO stands down

By Iain Gilbert

Date: Friday 17 Mar 2023

(Sharecast News) - Molecular diagnostic group Yourgene Health revealed on Friday that chief financial officer Barry Hextall will step down from his role, with immediate effect.

Total revenues tumble as Yourgene winds down Covid services

By Josh White

Date: Thursday 03 Nov 2022

(Sharecast News) - Molecular diagnostics specialist Yourgene said in a trading update on Thursday that its first-half core revenues were up 14% year-on-year at £8m.

Yourgene gets UK approval for 'Clarigene' Covid-19 test

By Josh White

Date: Thursday 17 Feb 2022

(Sharecast News) - Molecular diagnostic company Yourgene has received confirmation from the UK Health Security Agency that the 'Clarigene' SARS-CoV-2 test has been approved under the requirements set out in the Coronavirus Test Device Approvals regulations, it announced on Thursday.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

YGEN Market Data

Currency UK Pounds
Share Price 0.28p
Change Today -0.010p
% Change -3.36 %
52 Week High 10.00
52 Week Low 0.28
Volume 7,150,502
Shares Issued 3,176.96m
Market Cap £8.90m

YGEN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.04% above the market average68.04% above the market average68.04% above the market average68.04% above the market average68.04% above the market average
76.27% above the sector average76.27% above the sector average76.27% above the sector average76.27% above the sector average76.27% above the sector average
Price Trend
99.78% below the market average99.78% below the market average99.78% below the market average99.78% below the market average99.78% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
56.59% above the market average56.59% above the market average56.59% above the market average56.59% above the market average56.59% above the market average
76.19% above the sector average76.19% above the sector average76.19% above the sector average76.19% above the sector average76.19% above the sector average

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

YGEN Dividends

No dividends found

Trades for 29-Mar-2023

Time Volume / Share Price
15:45 164,932 @ 0.29p
12:30 1,000,000 @ 0.28p
12:27 1,000,000 @ 0.28p
12:01 1,300,000 @ 0.29p
11:58 3,500,000 @ 0.28p

YGEN Key Personnel

CEO Lyn Rees

Top of Page